Robert Califf does not appear to be actively packing his desk at US FDA's White Oak headquarters as the presidential election nears. He maintains that he would like to continue as agency commissioner even in the face of potential opposition from both candidates.
Califf, who has been in office less than a year, said Nov. 4 after a speech and discussion at Prevision Policy's Biopharma Congress in Washington, DC, that he is interested...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?